These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27809246)

  • 1. Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination.
    Dong Y; Chen YT; Yang YX; Shou D; Li CY
    Molecules; 2016 Oct; 21(11):. PubMed ID: 27809246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics Study of Type 2 Diabetes Mellitus and the AntiDiabetic Effect of Berberine in Zucker Diabetic Fatty Rats Using Uplc-ESI-Hdms.
    Dong Y; Chen YT; Yang YX; Zhou XJ; Dai SJ; Tong JF; Shou D; Li C
    Phytother Res; 2016 May; 30(5):823-8. PubMed ID: 26888689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.
    Jendle J; Hyötyläinen T; Orešič M; Nyström T
    Cardiovasc Diabetol; 2021 Dec; 20(1):237. PubMed ID: 34920733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis.
    Wang W; Zhao L; He Z; Wu N; Li Q; Qiu X; Zhou L; Wang D
    J Ethnopharmacol; 2018 Jun; 219():299-318. PubMed ID: 29580854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits.
    Nagaraju B; Anilkumar KV
    Indian J Pharmacol; 2021; 53(6):465-470. PubMed ID: 34975134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic analysis and biochemical changes in the urine and serum of streptozotocin-induced normal- and obese-diabetic rats.
    Mediani A; Abas F; Maulidiani M; Abu Bakar Sajak A; Khatib A; Tan CP; Ismail IS; Shaari K; Ismail A; Lajis NH
    J Physiol Biochem; 2018 Aug; 74(3):403-416. PubMed ID: 29766441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
    Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.
    Pelantová H; Bugáňová M; Holubová M; Šedivá B; Zemenová J; Sýkora D; Kaválková P; Haluzík M; Železná B; Maletínská L; Kuneš J; Kuzma M
    Mol Cell Endocrinol; 2016 Aug; 431():88-100. PubMed ID: 27164444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolomic analysis of the anti-diabetic effect of Ginseng berry in type II diabetic rats based on ultra high-performance liquid chromatography-high resolution mass spectrometry.
    Wang H; Huang R; Li H; Jiao L; Liu S; Wu W
    J Pharm Biomed Anal; 2021 Mar; 196():113897. PubMed ID: 33508764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats.
    Nistala R; Raja A; Pulakat L
    Can J Physiol Pharmacol; 2017 Mar; 95(3):281-287. PubMed ID: 28177677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats.
    Pandey S; Garabadu D
    Cell Mol Neurobiol; 2017 Jul; 37(5):791-802. PubMed ID: 27585927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic study of ginsenoside Rg3 and glimepiride in type 2 diabetic rats by liquid chromatography coupled with quadrupole-Orbitrap mass spectrometry.
    Yang D; Li X; Fu Y; Tao X; Zheng F; Yu J; Yue H; Dai Y
    Rapid Commun Mass Spectrom; 2021 Jun; 35(11):e9083. PubMed ID: 33742471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Novel Zebrafish Model for Type 2 Diabetes Mellitus.
    Zang L; Shimada Y; Nishimura N
    Sci Rep; 2017 May; 7(1):1461. PubMed ID: 28469250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus].
    Tang JZ; Mao JP; Yang ZF; Zhou ZG; Tang WL; Feng Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):631-4. PubMed ID: 16114544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.